Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karen Colwill

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
Transfusion|October 18, 2021
Resistance of SARS-CoV-2 beta and gamma variants to plasma collected from Canadian blood donors during the spring of 2020Steven J Drews, Kento T Abe, Queenie Hu, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 17, 2023
BNT162b2 versus mRNA-1273 Third Dose COVID-19 Vaccine in Patients with CKD and Maintenance Dialysis PatientsKevin Yau, Paul Tam, Christopher T Chan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 14, 2021
Persistence of T Cell and Antibody Responses to SARS-CoV-2 Up to 9 Months after Symptom OnsetJaclyn C Law, Melanie Girard, Gary Y C Chao, et al.
Iscience|April 19, 2023
COVID-19 vaccine antibody responses in community-dwelling adults to 48 weeks post primary vaccine seriesSharon L Walmsley, Leah Szadkowski, Bradly Wouters, et al.
Science Signaling|April 9, 2015
Integrative analysis of kinase networks in TRAIL-induced apoptosis provides a source of potential targets for combination therapyJonathan So, Adrian Pasculescu, Anna Y Dai, et al.
PLOS Global Public Health|September 10, 2024
High SARS-CoV-2 seroincidence but low excess COVID mortality in Sierra Leone in 2020-2022Ahmed Osman, Ashley Aimone, Rashid Ansumana, et al.
Heliyon|September 5, 2022
Comparative performance data for multiplex SARS-CoV-2 serological assays from a large panel of dried blood spot specimensFrançois Cholette, Rissa Fabia, Angela Harris, et al.
Nature Communications|September 27, 2023
Omicron variant neutralizing antibodies following BNT162b2 BA.4/5 versus mRNA-1273 BA.1 bivalent vaccination in patients with end-stage kidney diseaseKevin Yau, Alexandra Kurtesi, Freda Qi, et al.
Med (New York, N.Y.)|April 19, 2022
Immunogenicity of convalescent and vaccinated sera against clinical isolates of ancestral SARS-CoV-2, Beta, Delta, and Omicron variantsArinjay Banerjee, Jocelyne Lew, Andrea Kroeker, et al.
Elife|June 25, 2024
Hybrid immunity from severe acute respiratory syndrome coronavirus 2 infection and vaccination in Canadian adults: A cohort studyPatrick E Brown, Sze Hang Fu, Leslie Newcombe, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Transfusion|October 18, 2021
Resistance of SARS-CoV-2 beta and gamma variants to plasma collected from Canadian blood donors during the spring of 2020Steven J Drews, Kento T Abe, Queenie Hu, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 17, 2023
BNT162b2 versus mRNA-1273 Third Dose COVID-19 Vaccine in Patients with CKD and Maintenance Dialysis PatientsKevin Yau, Paul Tam, Christopher T Chan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 14, 2021
Persistence of T Cell and Antibody Responses to SARS-CoV-2 Up to 9 Months after Symptom OnsetJaclyn C Law, Melanie Girard, Gary Y C Chao, et al.
Iscience|April 19, 2023
COVID-19 vaccine antibody responses in community-dwelling adults to 48 weeks post primary vaccine seriesSharon L Walmsley, Leah Szadkowski, Bradly Wouters, et al.
Science Signaling|April 9, 2015
Integrative analysis of kinase networks in TRAIL-induced apoptosis provides a source of potential targets for combination therapyJonathan So, Adrian Pasculescu, Anna Y Dai, et al.
PLOS Global Public Health|September 10, 2024
High SARS-CoV-2 seroincidence but low excess COVID mortality in Sierra Leone in 2020-2022Ahmed Osman, Ashley Aimone, Rashid Ansumana, et al.
Heliyon|September 5, 2022
Comparative performance data for multiplex SARS-CoV-2 serological assays from a large panel of dried blood spot specimensFrançois Cholette, Rissa Fabia, Angela Harris, et al.
Nature Communications|September 27, 2023
Omicron variant neutralizing antibodies following BNT162b2 BA.4/5 versus mRNA-1273 BA.1 bivalent vaccination in patients with end-stage kidney diseaseKevin Yau, Alexandra Kurtesi, Freda Qi, et al.
Med (New York, N.Y.)|April 19, 2022
Immunogenicity of convalescent and vaccinated sera against clinical isolates of ancestral SARS-CoV-2, Beta, Delta, and Omicron variantsArinjay Banerjee, Jocelyne Lew, Andrea Kroeker, et al.
Elife|June 25, 2024
Hybrid immunity from severe acute respiratory syndrome coronavirus 2 infection and vaccination in Canadian adults: A cohort studyPatrick E Brown, Sze Hang Fu, Leslie Newcombe, et al.
Pageof 8